Last Posted: Jul 10, 2020
- A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes.
Peacock Oliver et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 Dec 45(12) 2241-2250 - Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.
Shin Seung Jun et al. Cancer research 2020 80(2) 354-360 - Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.
Mikhaylenko Dmitry S et al. Journal of oncology 2020 20207363102 - Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing
ML Thibodeau et al, Genetics in Medicine, June 6, 2020 - Guide to Hereditary Cancer Indications for Referral
- Hereditary cancer syndromes: Are your patients at risk? (CME)
- Understanding implementation success: protocol for an in-depth, mixed-methods process evaluation of a cluster randomised controlled trial testing methods to improve detection of Lynch syndrome in Australian hospitals.
Morrow April et al. BMJ open 2020 Jun 10(6) e033552 - A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection.
Velázquez Carolina et al. Journal of translational medicine 2020 Jun 18(1) 232 - Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study.
Bobbili Priyanka et al. Hereditary cancer in clinical practice 2020 1813 - Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer.
Snowsill Tristan M et al. Journal of clinical medicine 2020 Jun 9(6)
.png)
No hay comentarios:
Publicar un comentario